Insulet Corporation’s PODD Omnipod and Omnipod DASH insulin management systems recently received FDA’s approval for their use with Eli Lilly and Company’s LLY Lyumjev (insulin lispro-aabc injection) ...

Insulet Corporation PODD recently announced positive results from the first pivotal study for the Omnipod 5 Automated Insulin Delivery System. The finding of the study suggests that Omnipod 5 ...

The FDA has cleared the first tubeless automated insulin delivery system with a smartphone app control. The FDA has cleared Insulet’s Omnipod 5 automated insulin delivery system, marking the first ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Insulet Corp. reported positive results from a pivotal trial of its Omnipod 5 automated insulin delivery system for patients with type 1 diabetes. The tubeless, wearable insulin delivery system ...

Even without the rollout of the latest model of its tubeless insulin pump system—the Omnipod 5, which was originally poised to receive FDA clearance early last year but didn’t secure the agency’s OK ...

For young children with Type 1 diabetes and their parents, Insulet hopes its newest artificial pancreas system can make the “terrible twos” a little more manageable for everyone. After delivering ...

Question: How is the Omnipod system covered under Medicare now that my doctor and I are considering it to help control my diabetes? Answer: The Omnipod system is an insulin delivery system that allows ...

On the heels of launching Omnipod 5 in the United States, Insulet has received CE marking to sell the device in Europe. The Omnipod 5 is the first CE marked tubeless hybrid closed loop system (also ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the commercial launch of its ...